Log In

    Cocrystal Pharma Inc. (COCP)

    1Q24 Reported With Clinical Data Milestones On Schedule

    ‌
    Robert LeBoyerMedia Inquiries
    Senior Life Sciences Analyst
    May 14, 2024
    Report ID: 26747
    Get Report
    Refer to the full report for the price target, fundamental analysis, and rating.
    Get Report

    Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

    Already Registered? Click the ‘Get Report’ button to login and view the research report.

    Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

    ‌
    Cocrystal Pharma Inc.
    Cocrystal Pharma Inc.
    Healthcare
    Biotechnology
    Ticker
    COCP
    Current Price
    $2.2 -0.9%
    Market Cap
    $22.4M
    Price Target
    Refer to Report
    Volume
    9.4K
    52wk Range
    $1.325 - $3.285
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Related Research Reports
    7/19/2024
    ‌
    CDI-988 Reaches Milestone In Phase 1 Trial For Norovirus and Coronavirus
    CDI-988 Reaches Milestone In Phase 1 Trial For Norovirus and Coronavirus (COCP)
    0 min read
    6/21/2024
    ‌
    Cocrystal Updates Studies On Influenza and Bird Flu
    Cocrystal Updates Studies On Influenza and Bird Flu (COCP)
    4 min read
    5/14/2024
    ‌
    1Q24 Reported With Clinical Data Milestones On Schedule
    1Q24 Reported With Clinical Data Milestones On Schedule (COCP)
    0 min read
    11/14/2023
    ‌
    3Q23 Reported As Three Trials Make Progress
    3Q23 Reported As Three Trials Make Progress (COCP)
    2 min read

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In